Fundraising FoxGaruda Therapeutics
Cambridge, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Garuda Therapeutics
Sign up to see every warm intro you have to Garuda Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Garuda Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Garuda Therapeutics was founded in 2021 by Dhvanit I Shah.
DI
Dhvanit I ShahChief Executive Officer of the Issuer
DK
David KirskeExecutive
AC
Adam CraigExecutive
Board
GM
Geoff MeyersonBoard director
RK
Raymond KelleherBoard director
EA
SL
Steve LiapisBoard director
CG
Carl GordonBoard director
SG
Shaan GandhiBoard director
RS
Rahul SinghviBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$158M disclosed across 3 rounds · 2021–2024
▶$47.7MraisedOct 2024 · 16 investors · BiotechnologyRule 506(b)
▶$47.7MraisedOct 2024 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Geoff MeyersonDirector
- Raymond KelleherDirector
- Eric AguiarDirector
- Steve LiapisDirector
- Rahul SinghviDirector
- David KirskeExecutive Officer
- Carl GordonDirector
- Adam CraigExecutive Officer, Director
- Amount sold
- $47.7M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$62.1MraisedFeb 2023 · 13 investors · BiotechnologyRule 506(b)
▶$62.1MraisedFeb 2023 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel JanseDirector
- Eric AguiarDirector
- Carl GordonDirector
- Dhvanit I ShahExecutive Officer, Director
- Raymond KelleherDirector
- Rahul SinghviDirector
- Laurence ReidDirector
- Offering amount
- $62.9M
- Amount sold
- $62.1M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$48.1MraisedSep 2021 · 23 investors · BiotechnologyRule 506(b)
▶$48.1MraisedSep 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rahul SinghviDirector
- Eric AguiarDirector
- Shaan GandhiDirector
- Dhvanit I ShahExecutive Officer, Director
- Carl GordonDirector
- Offering amount
- $71.8M
- Amount sold
- $48.1M
- Sales commissions
- $2M
- Proceeds to insiders
- $970K
- Placement agents
- Locust Walk Securities, LLC
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Garuda Therapeutics?
- Garuda Therapeutics was founded by Dhvanit I Shah in 2021.
- Who are Garuda Therapeutics's investors?
- Garuda Therapeutics's investors include Aisling Capital.
- How much funding has Garuda Therapeutics raised?
- Garuda Therapeutics has disclosed $158M raised across 3 rounds.
- Where is Garuda Therapeutics headquartered?
- Garuda Therapeutics is headquartered in Cambridge, US.